NAUT
NAUT
NASDAQ · Life Sciences Tools & Services

Nautilus Biotechnology Inc

$1.87
+0.08 (+4.47%)
As of Jul 4, 2:06 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,320.3% upside
Low Target $24.26
Average Target $26.56
High Target $41.87
Current Price $1.87
Current
$1.87
Target
$26.56
$24.26 $26.56 avg $41.87
Scenario Analysis
Bear Case
$24.26
1,197.3%
Low target
Base Case
$26.56
+1,320.3%
Avg target
Bull Case
$41.87
+2,139.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.31
-56.6% from high
52-Week Low
$0.62
+201.6% from low
Target vs 52W High
$26.56
+516.2% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 85% $369.21 -29.5%
DHR
Danaher Corp
Strong Buy 30 90% $158.11 -20.1%
WAT
Waters Corp
Buy 28 57% $189.60 -50.0%
A
Agilent Technologies Inc
Strong Buy 28 79% $64.69 -50.5%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -59.9%
ILMN
Illumina Inc
Buy 28 61% $169.36 -10.2%
MTD
Mettler-Toledo International
Hold 20 50% $170.43 -87.0%
WST
West Pharmaceutical Services
Strong Buy 22 82% $136.24 -62.7%